Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer

Ovarian cancer treatment remains a challenge and targeting cancer stem cells presents a promising strategy. Niclosamide is an “old” antihelminthic drug that uncouples mitochondria of intestinal parasites. Although recent studies demonstrated that niclosamide could be a potential anticancer agent, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chi-Kang, Bai, Meng-Yi, Hu, Teh-Min, Wang, Yu-Chi, Chao, Tai-Kuang, Weng, Shao-Ju, Huang, Rui-Lan, Su, Po-Hsuan, Lai, Hung-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891020/
https://www.ncbi.nlm.nih.gov/pubmed/26848771
http://dx.doi.org/10.18632/oncotarget.7113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891020/
https://www.ncbi.nlm.nih.gov/pubmed/26848771
http://dx.doi.org/10.18632/oncotarget.7113

Ejemplares similares